Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hensel

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Emerging Infectious Diseases|January 26, 2022
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021Anna R Giuliano, Shari Pilon-Thomas, Michael J Schell, et al.
JAMA Oncology|March 10, 2022
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in FloridaAnna R Giuliano, Jeffrey E Lancet, Shari Pilon-Thomas, et al.
Journal of Biotechnology|September 16, 1999
Extended recombinant bacterial ghost systemW Lubitz, A Witte, F O Eko, et al.
Archives of Toxicology|February 7, 2026
Regulation of chemicals demands assessment of risks rather than identification of hazards onlyP Marx-Stoelting, V Ritz, M Herzler, et al.
Journal of Clinical Virology Plus|September 1, 2023
SARS-CoV-2 antibody response duration and neutralization following natural infectionChristopher W Dukes, Renata Am Rossetti, Jonathan A Hensel, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Emerging Infectious Diseases|January 26, 2022
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021Anna R Giuliano, Shari Pilon-Thomas, Michael J Schell, et al.
JAMA Oncology|March 10, 2022
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in FloridaAnna R Giuliano, Jeffrey E Lancet, Shari Pilon-Thomas, et al.
Journal of Biotechnology|September 16, 1999
Extended recombinant bacterial ghost systemW Lubitz, A Witte, F O Eko, et al.
Archives of Toxicology|February 7, 2026
Regulation of chemicals demands assessment of risks rather than identification of hazards onlyP Marx-Stoelting, V Ritz, M Herzler, et al.
Journal of Clinical Virology Plus|September 1, 2023
SARS-CoV-2 antibody response duration and neutralization following natural infectionChristopher W Dukes, Renata Am Rossetti, Jonathan A Hensel, et al.
Pageof 18